ArticleMolecules (Basel, Switzerland)2019

Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting.

Zhaoyi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.